AngioDynamics (ANGO) Tops Q3 EPS by 4c, Reaffirms FY Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.37 --0%
EPS Growth %: -200.0%
Financial Fact:
Cost of sales: 43.07M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -200.0%
Financial Fact:
Cost of sales: 43.07M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.03, $0.04 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $74 million versus the consensus estimate of $76.32 million.
GUIDANCE:
AngioDynamics sees FY2022 EPS of ($0.02)-$0.02, versus the consensus of ($0.01). AngioDynamics sees FY2022 revenue of $310-315 million, versus the consensus of $313.7 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Darden Restaurants (DRI) PT Raised to $235 at Guggenheim
- BTIG Starts Take-Two Interactive (TTWO) at Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
